CD19, Inhibitors

CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period as Autoimmune and Oncology Pipelines Accelerate | DelveInsight

19.03.2026 - 17:30:50 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom

en | boerse | 68882862 |